Featured News

COMPANY NEWS

Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements.

read more
First Lady of Virginia visits AMPEL

First Lady of Virginia visits AMPEL

Suzanne Youngkin shared the goals of the W+g initiative focused on wellbeing and workforce in Virginia during her March 30th visit to AMPEL BioSolutions, a women-owned business founded, headquartered and growing in Charlottesville.  The focus of AMPEL's business is...

read more
Trial of LuPRO mobile app predicts Lupus flares

Trial of LuPRO mobile app predicts Lupus flares

CLICK TO VIEW ORIGINAL ARTICLE > BY KATIE O'CONNOR, Richmond Times-Dispatch In 50 years, only one treatment was approved by the U.S. Food and Drug Administration to treat lupus, an autoimmune disease in which a person’s immune system attacks their healthy organs...

read more
Q&A: UVA-Trained Biotech Leader Setting Her Sights on Lupus

Q&A: UVA-Trained Biotech Leader Setting Her Sights on Lupus

CLICK TO READ ORIGINAL ARTICLE > by Fariss Samarrai, farisss@virginia.edu Lupus is a complex autoimmune disease that affects more than 1.4 million Americans. Its treatment in the United States alone costs about $7 billion per year. Despite this impact and cost, the...

read more

Pin It on Pinterest